Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Biochem Pharmacol. 2021 Jan 28;185:114428. doi: 10.1016/j.bcp.2021.114428

Figure 2.

Figure 2.

AHR canonical pathway. After ligand binding, chaperon proteins dissociate from the AHR/chaperon complex in the cytoplasm, leading the translocation of ligand-bound AHR into the nucleus. AHR/ligand heterodimerizes with ARNT in the nucleus, where they bind to XRE cis-elements of target genes, leading to their transactivation.